Drug intelligence / Profile preview

pyrantel + oxantel

Development stage
Phase 4
Lead developer
Ghent University
Modality
Small Molecules
Administration
Oral
01

Overview

Pyrantel + oxantel is a combination anthelmintic therapy composed of two tetrahydropyrimidine derivatives. Pyrantel is a broad-spectrum agent effective against common nematodes such as *Ascaris lumbricoides* (roundworm) and hookworms, while oxantel, an m-oxyphenol analog, provides targeted high efficacy against *Trichuris trichiura* (whipworm). Both components act as agonists at nicotinic acetylcholine receptors (nAChR) on the body-wall muscle of parasites, inducing persistent depolarization and spastic paralysis, which results in the detachment and expulsion of the worms from the host's gastrointestinal tract. The combination is characterized by poor intestinal absorption, ensuring high local concentrations at the site of infection and a favorable safety profile. University Ghent has conducted Phase 4 clinical research in Ethiopia evaluating this combination, often in conjunction with mebendazole, to improve treatment outcomes for trichuriasis in schoolchildren where standard single-dose benzimidazole treatments show limited effectiveness.

Other names
pyrantel-oxanteloxantel-pyrantel
02

Targets

α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)Tm-ACR-16 (Trichuris muris ACR-16-like nicotinic acetylcholine receptor)α3β2 nAChR (α3β2 nicotinic receptor)O-AChR (Trichuris suis oxantel-sensitive nicotinic acetylcholine receptor)

Beyond the preview

Go deeper on pyrantel + oxantel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pyrantel + oxantel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call